Nicotine
Cognitive · Nicotinic acetylcholine receptor agonist
Tier C
High-risk evidence profile
Bottom line
Read Off Label grades Nicotine as C (4.8/10) based on strong evidence, high benefit magnitude, and a very high addiction potential with all forms-risk safety profile.
Its high-risk evidence profile reflects a Safety score of 0/10; reported benefits and harms can differ by indication, dose, route, duration, and population.
Heishman 2010 meta confirmed cognitive benefits on attention, episodic/working memory in non-smokers at low doses.
Studied, labeled, or reported-use context: Lozenge/gum/patch 2-4 mg; cognitive use typically 1-2 mg acute — Unscheduled (nicotine); tobacco/vape products age-restricted; not individualized guidance.
If you were testing this on yourself
Two properties decide whether an n-of-1 experiment is readable and recoverable. These describe the experiment — they are not a judgment about whether to run it, and nothing here is a recommendation.
Can you undo it?
Slow to reverse
Pharmacologically short-acting, but dependence develops readily and is the reason this is not a clean experiment to stop. The compound reverses; the habit does not necessarily.
Can you tell if it worked?
Readable — Acute
Attention and reaction-time tasks.
What would fool you Tolerance and withdrawal set in fast enough that within days you are measuring relief of withdrawal rather than enhancement — the same trap as caffeine, but with a much stronger dependence liability. Any cognitive gain in a regular user is likely to be restoration of baseline.
What the evidence says
Heishman 2010 meta confirmed cognitive benefits on attention, episodic/working memory in non-smokers at low doses. Dependence can develop across nicotine delivery forms; intended occasional use can progress to repeated use. Non-combustible forms avoid combustion toxicity but not addiction/CV risk. Pregnancy exposure carries fetal and obstetric risks and is contraindicated in clinical guidance.
Mechanism
Non-selective nAChR agonist; stimulates α4β2 and α7 receptors; modulates dopamine, glutamate, GABA; acute attention/working memory enhancer in many paradigms
Studied, labeled, or reported dose & route
Lozenge/gum/patch 2-4 mg; cognitive use typically 1-2 mg acute
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about Nicotine's effects?
- Read Off Label rates the evidence for Nicotine as Strong and the benefit magnitude as high, producing an overall grade of C (4.8/10). Heishman 2010 meta confirmed cognitive benefits on attention, episodic/working memory in non-smokers at low doses.
- What safety findings are reported for Nicotine?
- Nicotine has a very high addiction potential with all forms risk profile in the database. Very High addiction potential with all forms; CV effects; teratogen; vasoconstriction Legal status: Unscheduled (nicotine); tobacco/vape products age-restricted.
- What does the low Safety score for Nicotine represent?
- The Safety score is 0/10. It records the substantial harms described for one or more use contexts; the Benefit score, indication, dose, route, duration, population, and legal status remain separate parts of the evidence profile.
- What doses or routes are reported for Nicotine?
- Lozenge/gum/patch 2-4 mg; cognitive use typically 1-2 mg acute This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does Nicotine work?
- Non-selective nAChR agonist; stimulates α4β2 and α7 receptors; modulates dopamine, glutamate, GABA; acute attention/working memory enhancer in many paradigms
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.